NASDAQ NMS - GLOBAL MARKET · CLGN
+6.64% · +$0.0206 · Vol 140.5K
Market closed · last close 4:00 PM ET · price as of 15:55:00 ET
Collplant Biotechnologies Ltd

Collplant Biotechnologies Ltd

Biotechnology
$0.3307
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
CLGN
Collplant Biotechnologies Ltd
Thu Aug 6 · session closed · Markets closed · resumes Fri 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

37/ 100
Veridion Score
SELL BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Thu Aug 6 · session closed · Markets closed · resumes Fri 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CLGN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CLGN catalysts
About Collplant Biotechnologies Ltd
Biotechnology
Listed since
2021
Employees
39
Country
IL

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.3164
Day high
$0.3500
Day low
$0.2896
Previous close
$0.3101
52W high
$3.15
-89.50% from high
52W low
$0.2728
2% of range
Market cap
$5.9M
EPS
$-1.0326
Beta
0.30
Shares out
18.9M
Volume
140.5K
3.73× rel vol
Avg volume
37.7K
VWAP
$0.3211
Price history computed in-house
1W
+10.27%
1M
-8.14%
3M
-17.78%
1Y
-88.06%
YTD
-76.38%
SMA 50 $0.3476 · below
SMA 200 $0.9734 · below
52W position 2%

CLGN overview

Veridion Score
37
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CLGN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CLGN Form 4 filings
Public disclosures

Congress activity in CLGN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CLGN in the cached public ledger.

Federal contracts

CLGN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CLGN in this window.
Lobbying spend

CLGN lobbying filings, year to date.

Registered lobbying filings matched to Collplant Biotechnologies Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CLGN in this window.
Loading news for CLGN
Analyst ratings
Sovereign unlock shows live analyst consensus for CLGN.
Options
Sovereign unlock shows live options positioning for CLGN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.